21st century perspective on chronic obstructive pulmonary disease

Respiration

Volumn 68, Issue 6, 2001, Pages 557-561

  Ward, Susan A ^a   Casaburi, Richard ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Epidemiology; Exercise intolerance; Genetics; Management; Pathogenesis; Therapeutics

Indexed keywords

AMFEBUTAMONE; BAMBUTEROL; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; METHYLXANTHINE; SALMETEROL; TIOTROPIUM BROMIDE;

CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; DISEASE COURSE; EARLY DIAGNOSIS; EMPHYSEMA; EXERCISE; HUMAN; LUNG RESECTION; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; RISK FACTOR; SMOKING CESSATION;

EXERCISE TOLERANCE; HUMANS; OXYGEN CONSUMPTION; PNEUMONECTOMY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY MUSCLES;

EID: 0035682110     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000063541     Document Type: Review

References (47)

1. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease
2. A world galloping into breathlessness
3. Statement: Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease
4. Optimal assessment and management of chronic obstructive pulmonary disease (COPD)
5. Epidemiology of chronic obstructive pulmonary disease (COPD)
6. Pathogenesis and pathology of COPD
7. Childhood viral infection and the pathogenesis of asthma and chronic obstructive lung disease
8. 1: The Lung Health
9. Prevalence of airways obstruction in a general population
10. Small airways diseases: Detection and insights with computed tomography
11. Virtual tools for imaging of the thorax
12. Novel techniques for MR imaging of pulmonary airspaces
13. Pulmonary ventilation imaged by magnetic resonance: At the doorstep of clinical application
14. Trends in chronic obstructive pulmonary disease mortality in Australia
15. Prevalence of obstructive lung disease and respiratory symptoms in Southern Sweden
16. Trends in the epidemiology of COPD in Canada, 1980 to 1995
17. Epidemiology of chronic obstructive lung disease
18. 1 decline, chronic obstructive pulmonary disease morbidity
19. Cellular and structural bases of chronic obstructive pulmonary disease
20. Future advances in COPD therapy
21. Pulmonary hypertension in COPD: Old and new concepts
22. Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease
23. Endothelins and pulmonary hypertension, what directions for the near future?
24. How and why exercise is impaired in COPD
25. Skeletal muscle dysfunction in chronic obstructive pulmonary disease
26. The skeletal muscle in chronic respiratory diseases
27. Respiratory muscle work compromises leg blood flow during maximal exercise
28. Clinical Exercise Testing
29. Physiologic benefits of exercise training in rehabilitation of patients with severe chronic obstructive pulmonary disease
30. Inferences from O2 uptake with respect to intramuscular [PCr] kinetics during moderate exercise in humans
31. 2 utilization? New insights into an old issue
32. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: The ISOLDE trial
33. Pulmonary Rehabilitation
34. Management of COPD: Surgical options
35. Patients at high risk of death after lung-volume-reduction surgery
36. Surgery for emphysema - Not for everyone
37. Lung-volume reduction surgery improves dyspnea, dynamic hy-perinflation, and respiratory muscle function
38. Improvement in pulmonary function and elastic recoil after lung-reduction surgery for diffuse emphysema
39. Exercise performance and gas exchange after bilateral video-assisted thoracoscopic lung volume reduction surgery for severe emphysema
40. Mechanisms of relief of exertional breathlessness following unilateral bullectomy and lung volume reduction surgery in emphysema
41. 1-anti-trypsin deficiency versus smoker's emphysema
42. Rationale and design of the National Emphysema treatment trial
43. New Drugs for Asthma, Allergy COPD
44. Skeletal muscle dysfunction in chronic obstructive pulmonary disease
45. Genetic risk factors for chronic obstructive pulmonary disease
46. Corticosteroid reversibility in COPD is related to features of asthma
47. Bronchial eosinophilia in exacerbation of bronchitis. An allergic profile of inflammation?